Tcw Group Inc Astrazeneca PLC Transaction History

Tcw Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $1.63 Million - $1.98 Million	-46,020 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$36.86 - $41.49 $15,112 - $17,010	410 Added 0.9%	46,020 $1.75 Million
Q3 2018 Oct 30, 2018	BUY	$34.76 - $39.72 $231,501 - $264,535	6,660 Added 17.1%	45,610 $1.81 Million
Q2 2018 Aug 02, 2018	BUY	$34.55 - $37.05 $374,867 - $401,992	10,850 Added 38.61%	38,950 $1.37 Million
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $60,994 - $67,765	1,850 Added 7.05%	28,100 $983,000
Q2 2017 Aug 11, 2017	BUY	N/A	26,250	26,250 $895,000

1,373

497M

5.14M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $202B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.